LGC retains Ministry of Defence drug testing contract to provide analytical support to the compulsory drug testing programme covering Army, Royal Navy, and Royal Air Force personnel
LGC reports that its contract has been renewed to provide analytical support to the UK Ministry of Defence's Compulsory Drug Testing (CDT) programme which covers Army, Royal Navy and Royal Air Force personnel throughout the world.
This is an exclusive contract and is for drug testing using both urine and hair samples.
LGC held the preceding MOD contracts from 1994.
The renewal of the contract coincidentally follows shortly after the one millionth MOD CDT urine sample being tested by LGC.
This milestone was marked recently at Trenchard Lines in Upavon, Wiltshire, the Adjutant General's headquarters, at which deputy chief of defence staff General AMD Palmer presented LGC with a certificate of appreciation for work in support of the programme.
Ric Treble, forensic quality manager at LGC, said: "LGC is very proud to have been competitively selected to support the MOD's compulsory drug testing programme and we are delighted to have been able to celebrate the testing of the one millionth drug testing sample for the Ministry.
"The range of LGC's toxicology services means that we are able to adapt our offering to meet MOD's individual requirements.
"We are committed to providing the best possible assistance to the MOD over the next five years, building on the well-established partnership of the last ten years".
LGC's drug and alcohol testing facilities are equipped to provide a legally defensible, independent and reliable service to support workplace drug and alcohol policies.
LGC says it can analyse a range of different sample types - body fluids, body tissue and hair - to identify the presence of a wide variety of substances including controlled drugs such as amphetamine, ecstasy, cocaine, and opiates.
LGC assists in the implementation of workplace drug and alcohol policies in both the public and private sectors, providing secure collection, full chain of custody, and rapid and fully accredited analysis of samples.